• About us
  • Membership
  • Contact us
  • Tue November 18, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • 15200

  • "Patterns of Friendship" exhibition highlights cultural ties between Iran, Russia  

  • Iran to showcase cultural products at Shahab international exhibition in Baghdad

  • 12 foreign documentaries to be shown at Portrait section of 19th Cinema Verite

  • Strategic reset in India-Afghanistan ties

  • Iran condemns new Israeli bloodshed in Gaza, West Bank

  • India’s return to America’s embrace

  • Top judge orders investigation into US June aggression against Iran

  • Aref tells Russian PM in Moscow: ‘Partnership treaty will guide us’

  • Israel arrests 27-year-old accused of spying for Iran in latest espionage case

  • How Tehran views recent Iraqi elections

  • Israel’s overlooked unraveling: The mass exodus and beyond

  • When water becomes politics

  • Sniper Safari in Sarajevo: We were in the crosshairs

  • Hezbollah vows Lebanon won’t surrender a single inch to Israel

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio